https://se.prisysbiotech.com/ Icke - Människan Primat Forskning Plattform & CRO | PRISYS Biotech https://se.prisysbiotech.com/uploads/39406/logo.png https://se.prisysbiotech.com/nhp-pharmacology/ NHP Farmakologi https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/biosafety-research/ Forskning om biosäkerhet https://se.prisysbiotech.com/uploads/202339406/p202303211456214933321.jpg https://se.prisysbiotech.com/pk-pd-adme/ PK PD ADME https://se.prisysbiotech.com/uploads/202339406/p202303211449418813566.jpg https://se.prisysbiotech.com/safety-evaluation/ Säkerhetsutvärdering https://se.prisysbiotech.com/uploads/202339406/p202303211451568197109.jpg https://se.prisysbiotech.com/translation-research/ Översättningsforskning https://se.prisysbiotech.com/uploads/202339406/p202303211454114300368.jpg https://se.prisysbiotech.com/nhp-pharmacology/non-human-primate.html Non-Human Primate (NHP) https://se.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg Non-Human Primate (NHP) https://se.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://se.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html The NHP Pharmacology Of Prisys https://se.prisysbiotech.com/uploads/39406/page/small/the-nhp-pharmacology-of-prisysb465a.jpg The NHP Pharmacology Of Prisys https://se.prisysbiotech.com/uploads/39406/page/the-nhp-pharmacology-of-prisysb465a.jpg https://se.prisysbiotech.com/pk-pd-adme/toxicokinetics.html Toxicokinetics https://se.prisysbiotech.com/uploads/39406/page/small/toxicokinetics7dc92.png Toxicokinetics https://se.prisysbiotech.com/uploads/39406/page/toxicokinetics7dc92.png https://se.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html Dose Range Finding Test https://se.prisysbiotech.com/uploads/39406/page/small/dose-range-finding-test1c040.png Dose Range Finding Test https://se.prisysbiotech.com/uploads/39406/page/dose-range-finding-test1c040.png https://se.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html Single-dose & Repeated Dose Toxicity Testing https://se.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg Single-dose & Repeated Dose Toxicity Testing https://se.prisysbiotech.com/uploads/39406/single-dose-repeated-dose-toxicity-testinga0b95.jpg https://se.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html What Is A NHP Study https://se.prisysbiotech.com/uploads/39406/small/what-is-a-nhp-study7f0f9.jpg What Is A NHP Study https://se.prisysbiotech.com/uploads/39406/what-is-a-nhp-study7f0f9.jpg https://se.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html AMD Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/amd-nonhuman-primates-disease-model78627.png AMD Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/amd-nonhuman-primates-disease-model78627.png https://se.prisysbiotech.com/biosafety-research/biosafetyresearch.html Biosafety Research https://se.prisysbiotech.com/uploads/39406/page/small/biosafetyresearchcd745.jpg Biosafety Research https://se.prisysbiotech.com/uploads/39406/page/biosafetyresearchcd745.jpg https://se.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html Pharmacokinetics https://se.prisysbiotech.com/uploads/39406/page/small/pharmacokinetics6a507.png Pharmacokinetics https://se.prisysbiotech.com/uploads/39406/page/pharmacokinetics6a507.png https://se.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html NHP Non-Alcoholic Steatohepatitis (NASH) Model https://se.prisysbiotech.com/uploads/39406/page/small/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png NHP Non-Alcoholic Steatohepatitis (NASH) Model https://se.prisysbiotech.com/uploads/39406/page/nhp-non-alcoholic-steatohepatitis-nash-modelbd73a.png https://se.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html NHP Acute Myocardial Infarction (AMI) Model https://se.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png NHP Acute Myocardial Infarction (AMI) Model https://se.prisysbiotech.com/uploads/39406/heart-failure-nonhuman-primates-disease-modela7712.png https://se.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html New And Modified Applications https://se.prisysbiotech.com/uploads/39406/page/small/new-and-modified-applicationsde315.png New And Modified Applications https://se.prisysbiotech.com/uploads/39406/page/new-and-modified-applicationsde315.png https://se.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html Glaucoma Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/glaucoma-nonhuman-primates-disease-model1d4d5.png Glaucoma Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/glaucoma-nonhuman-primates-disease-model1d4d5.png https://se.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html Psoriasis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/psoriasis-nonhuman-primates-disease-model6e94c.jpg Psoriasis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/psoriasis-nonhuman-primates-disease-model6e94c.jpg https://se.prisysbiotech.com/safety-evaluation/toxicology.html Toxicology https://se.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg Toxicology https://se.prisysbiotech.com/uploads/39406/toxicologycdb96.jpg https://se.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html Coagulation/Hemostasis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/202339406/small/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg Coagulation/Hemostasis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/202339406/coagulation-hemostasis-nonhuman-primates63c5ab02-c0b4-4eb9-b521-9658b5017498.jpg https://se.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html Pharmacodynamics https://se.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg Pharmacodynamics https://se.prisysbiotech.com/uploads/39406/pharmacodynamics620d3.jpg https://se.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://se.prisysbiotech.com/uploads/202339406/small/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg Non-Human Primate Model Renal Ischemia Reperfusion Injury (AKI To CKD Transition) https://se.prisysbiotech.com/uploads/202339406/non-human-primate-model-renal-ischemia7ddb4a21-f360-4251-a51c-3cdb367eb3ad.jpg https://se.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html NHP Lung Fibrosis Model https://se.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg NHP Lung Fibrosis Model https://se.prisysbiotech.com/uploads/39406/nhp-lung-fibrosis-model25cd4.jpg https://se.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html Rheumatoid Arthritis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/rheumatoid-arthritis-nhp-model438fa.jpg Rheumatoid Arthritis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/rheumatoid-arthritis-nhp-model438fa.jpg https://se.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html Hemophilia A Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/202339406/small/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg Hemophilia A Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/202339406/hemophilia-a-nonhuman-primates-disease-model4c747716-98c5-4ef0-a508-55e7790a46ff.jpg https://se.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html NHP Asthma/atopic Dermatitis Model https://se.prisysbiotech.com/uploads/39406/page/small/nhp-asthma-atopic-dermatitis-model85f50.png NHP Asthma/atopic Dermatitis Model https://se.prisysbiotech.com/uploads/39406/page/nhp-asthma-atopic-dermatitis-model85f50.png https://se.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/tdar-nonhuman-primates-disease-modelae31c.jpg T Cell Dependent Antibody Response(TDAR) Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/tdar-nonhuman-primates-disease-modelae31c.jpg https://se.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html Inflammatory Bowel Disease Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/inflammatory-bowel-nhp-disease-modela21ae.png Inflammatory Bowel Disease Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/inflammatory-bowel-nhp-disease-modela21ae.png https://se.prisysbiotech.com/pk-pd-adme/adme.html ADME https://se.prisysbiotech.com/uploads/39406/adme55f5d.jpg ADME https://se.prisysbiotech.com/uploads/39406/adme55f5d.jpg https://se.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html NHP(monkey) Disease Models https://se.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png NHP(monkey) Disease Models https://se.prisysbiotech.com/uploads/39406/nhp-monkey-disease-models0f6a0.png https://se.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/delayed-type-hypersensitivity-dth-nonhuman90003.jpg Delayed-type Hypersensitivity (DTH) Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/delayed-type-hypersensitivity-dth-nonhuman90003.jpg https://se.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html Epilepsy Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/epilepsy-nhp-model4f142.jpg Epilepsy Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/epilepsy-nhp-model4f142.jpg https://se.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html Multiple Sclerosis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg Multiple Sclerosis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/202339406/multiple-sclerosis-nhp-modelac9f75fb-b6ef-46d4-867c-1ad7b769490b.jpg https://se.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://se.prisysbiotech.com/uploads/39406/page/small/nhp-chronic-obstructive-pulmonary-disease1524e.png NHP Chronic Obstructive Pulmonary Disease (COPD) Model https://se.prisysbiotech.com/uploads/39406/page/nhp-chronic-obstructive-pulmonary-disease1524e.png https://se.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html Uveitis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/uveitis-nonhuman-primates-disease-modele962a.png Uveitis Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/uveitis-nonhuman-primates-disease-modele962a.png https://se.prisysbiotech.com/translation-research/nhpresources.html NHP Resources https://se.prisysbiotech.com/uploads/39406/page/small/nhpresources90325.jpg NHP Resources https://se.prisysbiotech.com/uploads/39406/page/nhpresources90325.jpg https://se.prisysbiotech.com/translation-research/translational-studies.html Translational Studies https://se.prisysbiotech.com/uploads/39406/page/small/translational-studies5e517.png Translational Studies https://se.prisysbiotech.com/uploads/39406/page/translational-studies5e517.png https://se.prisysbiotech.com/safety-evaluation/immunotoxicity.html Immunotoxicity Testing and NHP Drug Safety Evaluation https://se.prisysbiotech.com/uploads/39406/small/immunotoxicity35901.jpg Immunotoxicity Testing and NHP Drug Safety Evaluation https://se.prisysbiotech.com/uploads/39406/immunotoxicity35901.jpg https://se.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/embolism-nonhuman-primates-disease-model4e2cf.png Pulmonary Artery Hypertension/Embolism Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/embolism-nonhuman-primates-disease-model4e2cf.png https://se.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://se.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg Middle Cerebral Artery Occlusion (MCAO) NHP Model Of Stoke & Brain Ischemia https://se.prisysbiotech.com/uploads/202339406/mcao-nhp-model0cf8cbb0-48b5-473b-b725-fd749c9c69ca.jpg https://se.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html Myopia Hyperopia Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/myopia-hyperopia-nhp-model745fb.png Myopia Hyperopia Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/myopia-hyperopia-nhp-model745fb.png https://se.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html Neuropathic Pain Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/neuropathic-pain-nhp-model48d12.png Neuropathic Pain Nonhuman Primates Disease Model https://se.prisysbiotech.com/uploads/39406/page/neuropathic-pain-nhp-model48d12.png https://se.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html ClearPoint Navigation For CNS Research https://se.prisysbiotech.com/uploads/39406/page/small/clearpoint-navigation-for-cns-researchf4cb9.jpg ClearPoint Navigation For CNS Research https://se.prisysbiotech.com/uploads/39406/page/clearpoint-navigation-for-cns-researchf4cb9.jpg https://se.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html AI-based NHP Behavior Analysis System https://se.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png AI-based NHP Behavior Analysis System https://se.prisysbiotech.com/uploads/39406/ai-based-nhp-behavior-analysis-systema5d80.png https://se.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html Parkinson's Disease Model https://se.prisysbiotech.com/uploads/39406/page/small/parkinson-s-disease-model9ce85.jpg Parkinson's Disease Model https://se.prisysbiotech.com/uploads/39406/page/parkinson-s-disease-model9ce85.jpg https://se.prisysbiotech.com/translation-research/clinical-imaging.html Klinisk avbildning https://se.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Klinisk avbildning https://se.prisysbiotech.com/uploads/39406/clinical-imaging585d0.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/small/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/clinical-imagingb514bd15-133f-4e9b-a75a-0e1cbbc1f4f0.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/small/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/clinical-imagingb9ae57aa-6754-41ce-822c-46e3f1c3d84a.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/small/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/clinical-imaginga1e6f856-06fb-4365-aa1c-53949acb37af.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/small/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg Clinical Imaging https://se.prisysbiotech.com/uploads/202439406/clinical-imagingb127b97f-7b00-4335-b905-64e36f57247d.jpg https://se.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html Immunosuppression Model https://se.prisysbiotech.com/uploads/39406/page/small/immunosuppression-model9e95e.jpg Immunosuppression Model https://se.prisysbiotech.com/uploads/39406/page/immunosuppression-model9e95e.jpg https://se.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html Type 1 Diabetes Mellitus Model https://se.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png Type 1 Diabetes Mellitus Model https://se.prisysbiotech.com/uploads/39406/type-1-diabetes-mellitus-modelbc16f.png https://se.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html Typ 2-diabetes mellitusmodell https://se.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png Typ 2-diabetes mellitusmodell https://se.prisysbiotech.com/uploads/39406/type-2-diabetes-mellitus-model5981d.png https://se.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html Renal Fibrosis Model https://se.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg Renal Fibrosis Model https://se.prisysbiotech.com/uploads/39406/renal-fibrosis-modelb87a4.jpg https://se.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html Hyperlipoidemia Model https://se.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png Hyperlipoidemia Model https://se.prisysbiotech.com/uploads/39406/hyperlipoidemia-modeldc1b0.png https://se.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html Endometriosis Model https://se.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png Endometriosis Model https://se.prisysbiotech.com/uploads/39406/endometriosis-modeldd994.png https://se.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html A-V Shunt Model https://se.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg A-V Shunt Model https://se.prisysbiotech.com/uploads/39406/a-v-shunt-modelef93d.jpg https://se.prisysbiotech.com/clearpoint/nhp-neuroscience.html NHP Neuroscience https://se.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg NHP Neuroscience https://se.prisysbiotech.com/uploads/39406/nhp-neuroscience94a5c.jpg https://se.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html Convection-Enhanced Delivery (CED) Technology https://se.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png Convection-Enhanced Delivery (CED) Technology https://se.prisysbiotech.com/uploads/39406/convection-enhanced-delivery-ced-technology7e74b.png https://se.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html Pruritus NHP Model https://se.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg Pruritus NHP Model https://se.prisysbiotech.com/uploads/39406/pruritus-nhp-modelfcbdb.jpg https://se.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html Atopic Dermatitis NHP Model https://se.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg Atopic Dermatitis NHP Model https://se.prisysbiotech.com/uploads/39406/atopic-dermatitis-nhp-model0fc1f.jpg https://se.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html Targeted Organ Drug Delivery Platform in NHP https://se.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png Targeted Organ Drug Delivery Platform in NHP https://se.prisysbiotech.com/uploads/39406/targeted-organ-drug-delivery-platform-in-nhpe13f9.png https://se.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html Inflammatory Bowel Disease IBD NHP Model https://se.prisysbiotech.com/uploads/39406/small/inflammatory-bowel-disease-ibd-nhp-model048b6.png Inflammatory Bowel Disease IBD NHP Model https://se.prisysbiotech.com/uploads/39406/inflammatory-bowel-disease-ibd-nhp-model048b6.png https://se.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html AAV-α-Synuclein Overexpression NHP Model https://se.prisysbiotech.com/uploads/39406/small/aav-synuclein-overexpression-nhp-model93460.jpg AAV-α-Synuclein Overexpression NHP Model https://se.prisysbiotech.com/uploads/39406/aav-synuclein-overexpression-nhp-model93460.jpg https://se.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html Heart Failure NHP Model https://se.prisysbiotech.com/uploads/39406/small/heart-failure-nhp-model8c759.jpg Heart Failure NHP Model https://se.prisysbiotech.com/uploads/39406/heart-failure-nhp-model8c759.jpg https://se.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html Acute Lung Inflammation (ALI) NHP Model https://se.prisysbiotech.com/uploads/39406/page/small/acute-lung-inflammation-ali-nhp-modelcce6e.png Acute Lung Inflammation (ALI) NHP Model https://se.prisysbiotech.com/uploads/39406/page/acute-lung-inflammation-ali-nhp-modelcce6e.png https://se.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html Nose-to-Brain Drug Delivery https://se.prisysbiotech.com/uploads/39406/small/nose-to-brain-drug-delivery15a9e.jpg Nose-to-Brain Drug Delivery https://se.prisysbiotech.com/uploads/39406/nose-to-brain-drug-delivery15a9e.jpg https://se.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html Acute Hemorrhagic Shock Model NHP Model https://se.prisysbiotech.com/uploads/39406/small/acute-hemorrhagic-shock-model-nhp-model5b827.png Acute Hemorrhagic Shock Model NHP Model https://se.prisysbiotech.com/uploads/39406/acute-hemorrhagic-shock-model-nhp-model5b827.png https://se.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html Retinitis Pigmentosa (RP) NHP Model https://se.prisysbiotech.com/uploads/39406/small/retinitis-pigmentosa-rp-nhp-model49f0f.png Retinitis Pigmentosa (RP) NHP Model https://se.prisysbiotech.com/uploads/39406/retinitis-pigmentosa-rp-nhp-model49f0f.png https://se.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html Liver Fibrosis Model https://se.prisysbiotech.com/uploads/39406/small/liver-fibrosis-modelc2688.png Liver Fibrosis Model https://se.prisysbiotech.com/uploads/39406/liver-fibrosis-modelc2688.png https://se.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://se.prisysbiotech.com/uploads/39406/small/nhp-intrathecal-dosing-csf-samplingb3e80.png NHP Intrathecal (IT) Injection & CSF Sampling Services | Prisys Biotech https://se.prisysbiotech.com/uploads/39406/nhp-intrathecal-dosing-csf-samplingb3e80.png https://se.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html NHP Intracerebral (ICM) Injection| Prisys Biotech https://se.prisysbiotech.com/uploads/39406/small/nhp-intracerebral-injection-icm-servicesbbf15.jpg NHP Intracerebral (ICM) Injection| Prisys Biotech https://se.prisysbiotech.com/uploads/39406/nhp-intracerebral-injection-icm-servicesbbf15.jpg https://se.prisysbiotech.com/translation-research/biodistribution-imaging-service.html Biodistribution Imaging Service https://se.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png Biodistribution Imaging Service https://se.prisysbiotech.com/uploads/39406/biodistribution-imaging-serviceabec3.png https://se.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://se.prisysbiotech.com/uploads/39406/small/dsa-guided-interventional-platformb8fb1.png DSA-Guided Interventional Platform For NHP Research | Prisys Biotech https://se.prisysbiotech.com/uploads/39406/dsa-guided-interventional-platformb8fb1.png https://se.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://se.prisysbiotech.com/uploads/39406/page/small/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg Focal Segmental Glomerulosclerosis (FSGS) NHP Model https://se.prisysbiotech.com/uploads/39406/page/nhp-focal-segmental-glomerulosclerosis-fsgsd2851.jpg https://se.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://se.prisysbiotech.com/uploads/39406/small/nhp-intracerebroventricular-icv-injectionccb4c.png NHP Intracerebroventricular (ICV) Injection | Prisys Biotech https://se.prisysbiotech.com/uploads/39406/nhp-intracerebroventricular-icv-injectionccb4c.png https://se.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003107477988352.html Molecular Imaging i NHP-modeller för translationell läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n20260817131455786a8.jpg https://se.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968072987337728.html NHP BehaviorAtlas webbseminarium|3D NHP beteendespårning för läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n20260706130958536b1.png https://se.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724349749437440.html Sammanfattning 2025: Hur Prisys omdefinierar translationell tillförlitlighet i NHP-forskning https://se.prisysbiotech.com/uploads/39406/news/n20260115105444c1b0c.jpg https://se.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17559672989721600.html NHP - Baserad farmakologi och farmakodynamiska tjänster|Prisys bioteknik https://se.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://se.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17529863054418944.html Möt Prisys Biotech på kommande EU Roadshow: september 2025 https://se.prisysbiotech.com/uploads/39406/news/n2025082013335410dba.jpg https://se.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17456099772015616.html Prisys Biotech-2025 Mid-Year Review https://se.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://se.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243129186608128.html Möt Prisys i det kommande USA-vägshowen i mars 2025 https://se.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://se.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83978023.html PRISYS Årsrapport 2024: Avancering av NHP-modeller och preklinisk forskning https://se.prisysbiotech.com/uploads/39406/news/n20241204135917ca94f.jpg https://se.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77754331.html Prisys Biotech 2024 Q2 Newsletter - Förbättrad preklinisk FoU för CNS-terapi med PRISYS korsreaktiva modeller https://se.prisysbiotech.com/uploads/39406/news/n20240520124055bc2de.png https://se.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028052418683904.html Varför djurmodeller lyckas eller misslyckas i drogutveckling https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021126514861056.html Kvantitativt PET-målengagemang i NHP för CNS-läkemedel https://se.prisysbiotech.com/uploads/39406/news/n202608261535298f0fc.png https://se.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18014938445227008.html Från video till data: 3D AI-spårning för NHP-beteende https://se.prisysbiotech.com/uploads/39406/news/p2026082115534501025.png https://se.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015016947147776.html PET Biodistribution Imaging i icke-mänskliga primater https://se.prisysbiotech.com/uploads/39406/news/n202608191309007190a.png https://se.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003107654542336.html PBPK vs. Fackmodeller: Varför PBPK betyder något https://se.prisysbiotech.com/uploads/39406/news/n20260814103950d26c5.jpg https://se.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17992982079988736.html Sammanfattning av webbseminarium: Avancera translationell NHP-forskning genom digital beteendefenotypning https://se.prisysbiotech.com/uploads/39406/news/n20260807130040f7d24.png https://se.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990258205680640.html PK biomarkörer i preklinisk läkemedelsutveckling|Exponering–Respons & PK/PD https://se.prisysbiotech.com/uploads/39406/news/n20260805152832759f2.png https://se.prisysbiotech.com/news/behavior-in-rhesus-17983350022431744.html Spontaneous Self-Injurious Behaviour in Rhesus Macaques: A Translational NHP Model For Neuropsychiatric Drug Development https://se.prisysbiotech.com/uploads/39406/news/n20260731163230fd87d.png https://se.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983338288849920.html MIDD och NHP effektivitetsmodeller i translationell läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n2026073013213937533.png https://se.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973035492418560.html AI-Driv 3D NHP beteendeanalys|Markörlös beteendefenotypning https://se.prisysbiotech.com/uploads/39406/news/n20260723161948c057f.png https://se.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973035569406976.html Globalt webbseminarium|Kvantifiera komplexa NHP-beteenden: Vi introducerar NHP BehaviorAtlas for High-Fidelity 3D Behavioral Phenotyping https://se.prisysbiotech.com/uploads/39406/news/n20260721164252b91dc.jpg https://se.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968072730403840.html AI-Driv NHP-beteendeanalys för preklinisk läkemedelsutveckling|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202607171631204cfce.png https://se.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973050696705024.html När ska man införa NHP-studier i utveckling av autoimmun läkemedel https://se.prisysbiotech.com/uploads/39406/news/n2026071314114600533.png https://se.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973036206941184.html NHP IBD-modeller: vad kronisk enterokolit i rhesusmakaker lär oss om translationell tarminflammation https://se.prisysbiotech.com/uploads/39406/news/n20260710141850796f6.png https://se.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973035436385280.html MRI-Guidad AAV-leverans i NHP-hjärnmodeller för CNS-genterapi https://se.prisysbiotech.com/uploads/39406/news/n202607071035506b1ed.png https://se.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973036035154944.html Varför positiva kontrollläkemedel är viktiga i modeller för autoimmuna sjukdomar|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202607011605210dd31.png https://se.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973035592786944.html Baslinje ADA-screening hos tvättade-apor för prekliniska biologiska studier https://se.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://se.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968073312936960.html Smärtmekanismer: UVB-solbränningsmodellen är ett viktigt translationsverktyg https://se.prisysbiotech.com/uploads/39406/news/n202606261052354a6de.jpg https://se.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968072691770368.html NHP-modeller för maternal hög-fettdiet och programmering av fetma hos barn https://se.prisysbiotech.com/uploads/39406/news/n20260626101823325bd.jpg https://se.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17937921223353344.html Tolkning av klinisk patologi hos hundar och icke-mänskliga primater i prekliniska studier https://se.prisysbiotech.com/uploads/39406/news/n20260623143229ac184.jpg https://se.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17937922054333440.html Molecular Imaging Biomarkers: Advancing Translational Research and Drug Development https://se.prisysbiotech.com/uploads/39406/news/n202606181451278625b.png https://se.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17937935101731840.html Vad är icke-linjär farmakokinetik? Mekanismer, egenskaper och konsekvenser för läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n20260616141042be995.jpg https://se.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17937935123981312.html Varför NHP Molecular Imaging är avgörande för translationella PET-studier https://se.prisysbiotech.com/uploads/39406/news/n202606121112387f111.jpg https://se.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17937921731699712.html Vad är molekylär avbildning och varför är det viktigt i läkemedelsutveckling? https://se.prisysbiotech.com/uploads/39406/news/n2026061013321190d5a.jpg https://se.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17937922683020288.html NHP Radionuclid Biodistribution Studies: Molecular Imaging for Translational Drug Development https://se.prisysbiotech.com/uploads/39406/news/n2026060515134174d47.jpg https://se.prisysbiotech.com/news/nhp-heart-failure-model-17937921720984576.html NHP hjärtsviktsmodell stöder translationell forskning om genterapi för telomeråterställning https://se.prisysbiotech.com/uploads/39406/news/n20260602142703b954a.png https://se.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17937921273684992.html Hur DSA och CTA Imaging förbättrar kardiovaskulär läkemedelssäkerhetsutvärdering https://se.prisysbiotech.com/uploads/39406/news/n2026052913380640f74.jpg https://se.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17937921089233920.html NHP arteriovenös shunttrombosmodell hos cynomolgusapor för translationell antitrombotisk läkemedelsutvärdering https://se.prisysbiotech.com/uploads/39406/news/n20260527103349ad81a.jpg https://se.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888295219258368.html Farmakokinetiska data som en translationell biomarkör https://se.prisysbiotech.com/uploads/39406/news/n202605211329439d160.jpg https://se.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888295539401728.html Icke-mänskliga primatmodeller av lungfibros: förstärkning av translationell noggrannhet i utveckling av respiratoriska läkemedel https://se.prisysbiotech.com/uploads/39406/news/n20260515153544ef082.jpg https://se.prisysbiotech.com/news/nhp-models-translational-drug-development-17888295832773632.html Varför läkemedelsutveckling blir alltmer beroende av NHP-modeller|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260514093832593bb.jpg https://se.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888295532536832.html PK-data som en farmakodynamisk biomarkör: främja translationell läkemedelsutveckling genom kvantitativ farmakologi https://se.prisysbiotech.com/uploads/39406/news/n202605091519031a196.jpg https://se.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17852131140412416.html Icke-GLP-farmakologistudier för regulatorisk inlämning: dataintegritet och laboratoriekrav https://se.prisysbiotech.com/uploads/39406/news/n20260424104846a67ea.jpg https://se.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17852130740937728.html Strategisk design av icke-kliniska farmakokinetiska studier: från ADME-profilering till translationellt beslut- https://se.prisysbiotech.com/uploads/39406/news/n202604201042394eb2f.jpg https://se.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17852130767053824.html NHP AV-Shunttrombosmodell för läkemedelssäkerhetsutvärdering|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260417154405f8553.jpg https://se.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17852129594762240.html Vad är icke-linjär farmakokinetik? Mekanismer och translationell PK-utvärdering|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260414144233849f1.png https://se.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17852120041759744.html Prisys Biotech stöder IND-godkännande av UX-GIP001 av FDA och CDE|NHP CNS Delivery Platform https://img01.v15cdn.com/gallery/4x3/157.webp https://se.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17852120153187328.html In vivo immuncellspårning och utveckling av PET-spårämnen i NHP-modeller|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202604021117547afde.jpg https://se.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17852120155071488.html Dopamine Transporter PET Imaging i NHP-modeller|CNS-avbildning|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n2026033113465773e8f.jpg https://se.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17852119672136704.html PET/CT-biodistribution i NHP-modeller för CNS-läkemedelsleverans|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202603271731432da82.jpg https://se.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17852120049886208.html Stor-radiomärkning av djur och in vivo-avbildningsplattform för translationell läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n20260323111154bf8b7.jpg https://se.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17852119701742592.html Varför läkemedelsutveckling i allt högre grad förlitar sig på NHP-modeller: primaternas väsentliga roll i translationell medicin|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260320115823340b4.png https://se.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17852120115766272.html IPF Drug Development Utmaningar och lösningar|NHP-modeller med CT-bilder och PFT https://se.prisysbiotech.com/uploads/39406/news/n2026031715015159514.png https://se.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17852119834469376.html AI Markerless NHP 3D beteendeanalyssystem för preklinisk forskning https://se.prisysbiotech.com/uploads/39406/news/n20260313142823bc65b.png https://se.prisysbiotech.com/news/evaluating-dmpk-properties-17852119648887808.html Utvärdering av DMPK-egenskaper hos kandidatföreningar vid tidig upptäckt av läkemedel|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260310153743383ae.jpg https://se.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17852119650624512.html MRI-Guidad CNS-leverans i NHP-modeller|Translationell IMRI & CED-plattform https://se.prisysbiotech.com/uploads/39406/news/n202602261246469558e.png https://se.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17852119879099392.html NHP CNS Biodistribution Studies|Intratekal RNA-leverans|PRISYS Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260214120241d2f33.jpg https://se.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17852119957398528.html Translationellt PK/PD-ramverk: Förutsägelse av dos från Cynomolgus Monkey till mänsklig|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260213142144bd00d.png https://se.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724349965296640.html När smärta blir ett minne: känslomässiga drivkrafter för kronisk smärta och fördelen med NHP-modellen|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n2026012713131077473.jpg https://se.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724349729022976.html Multi-Endpoint Pain Assessment: The Future Of Analgesic Drug Development https://se.prisysbiotech.com/uploads/39406/news/n20260123153636bce28.jpg https://se.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724349797655552.html Varför misslyckas så många analgetika i prekliniska prövningar? Svaret ligger i hur vi mäter smärta https://se.prisysbiotech.com/uploads/39406/news/n20260120155944a4ef1.jpg https://se.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724350008009728.html Tidpunktsdesign för blodprovtagning i farmakokinetiska (PK) studier|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n2026011316592151314.jpg https://se.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724350368637952.html PK-statistik: parametrar för icke-kompartmentanalys (NCA) och prekliniska tillämpningar https://se.prisysbiotech.com/uploads/39406/news/n20260109161837141c9.jpg https://se.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724349859079168.html Varför icke-mänskliga primatmodeller är kritiska för CNS-oligonukleotidterapi https://se.prisysbiotech.com/uploads/39406/news/n20260106130909b5b92.jpg https://se.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724350020150272.html Urinsyrametabolism hos människor vs apor: translationella konsekvenser för läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/2026010416213306463.jpg https://se.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724349735445504.html Icke-Human Primate MASH-associerad leverfibrosmodell|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/p20251226155519da3af.png https://se.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724349808337920.html Varför IMRI-Guided Brain Drug Delivery är avgörande för exakt inriktning i NHP-studier https://se.prisysbiotech.com/uploads/39406/news/n202512231619222564f.png https://se.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674710515115008.html AI-drivet markörlöst NHP 3D beteendeanalyssystem|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202512181608129079f.jpg https://se.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674682209559552.html LPS-Inducerad akut lunginflammation (ALI) NHP-modell|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202512161502375ccdb.jpg https://se.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674710818317312.html HDM+SEB-Modell för inducerad atopisk dermatit (AtD) hos Cynomolgusapor https://se.prisysbiotech.com/uploads/39406/news/n20251212144449750c1.jpg https://se.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674682551968768.html En- till flera-fack PK-modeller förklaras|NHP Farmakokinetik|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20251208140839d8db0.jpg https://se.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674710821643264.html Hur man väljer en pålitlig preklinisk CRO|Nyckelkriterier för bioteknikföretag|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20251204133731f364a.jpg https://se.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674704688063488.html Translationell CAR-T-utvärdering: In vitro-expertis och NHP-studiestöd – Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202512011123451e873.png https://se.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674710966150144.html Varför misslyckas mer än 90 % av CNS-läkemedelskandidaterna i kliniska prövningar? https://se.prisysbiotech.com/uploads/39406/news/n202511281410270841e.png https://se.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674686396654592.html Prekliniska modeller för Parkinsons sjukdom: En guide till att välja neurotoxin, genetiska och NHP-modeller|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n2025112415472074828.png https://se.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674682365862912.html Hög-precisionsläkemedelsleverans och AI-drivna NHP translationella plattformar https://se.prisysbiotech.com/uploads/39406/news/n2025112108401436404.jpg https://se.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17631421757105152.html Th17-drivna NHP-immunologimodeller|Translationell autoimmun forskning på Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20251117110751844f3.png https://se.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17631421941670912.html AI-Baserat NHP BehaviorAtlas®-system|Plattform för 3D beteendeanalys|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20251114162428314a9.png https://se.prisysbiotech.com/news/rfp-template-for-nhp-studies-17631421899138048.html RFP-mall för NHP-studier|Accelerera preklinisk forskningseffektivitet https://se.prisysbiotech.com/uploads/39406/news/n2025111015483953c4b.jpg https://se.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17631421602620416.html Kall Allodynia Pain Model i Cynomolgus Monkeys|Prisys Biotechnologies https://se.prisysbiotech.com/uploads/39406/news/n20251107160515acddb.jpg https://se.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17631421912327168.html MRT-Guidad plattform för intracerebral läkemedelsleverans|Prisys Biotech CNS Research https://se.prisysbiotech.com/uploads/39406/news/n2025110514460235db1.jpg https://se.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17631424557638656.html NHP-modeller för luftvägssjukdomar och plattform för leverans av läkemedel i luftvägar|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20251028164336adaf3.png https://se.prisysbiotech.com/news/nhp-renal-biopsy-17631422127662080.html NHP njurbiopsiplattform och modeller för njursjukdomar|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/276.webp https://se.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17631422004651008.html PK-studier & riktad läkemedelsleverans|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202510171638300dafe.jpg https://se.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17631421798704128.html Prisys Biotechnologies NHP Research and AI-Based Behavioral Analysis Platform https://se.prisysbiotech.com/uploads/39406/news/n2025101517485012ee9.jpg https://se.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17631421699269632.html Nasal-till-hjärna (N2B) leveransteknik för CNS-forskning|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20251011133522c7c7b.jpg https://se.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17631421594280960.html SHR-2004: Ett genombrott inom VTE-prevention för patienter med äggstockscancer – en framgångshistoria av Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n2025101011280623985.jpg https://se.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540556731048960.html Cynomolgus & Rhesus Monkey Modeller|Prisys Biotech Preclinical CRO https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17529863052452864.html Idiopatisk lungfibros (IPF) NHP -modell|Prisys bioteknik preklinisk CRO https://se.prisysbiotech.com/uploads/39406/news/n20250912151948fd2c4.jpg https://se.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17529862998074368.html Cynomolgus Monkey Biodistribution Studies|Prisys Biotech Preclinical CRO https://se.prisysbiotech.com/uploads/39406/news/n202509091635226f118.jpg https://se.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17529863543055360.html Prisys Biotech NHP -modeller för hematologi och strokeforskning https://se.prisysbiotech.com/uploads/39406/news/n20250903101944cac91.jpg https://se.prisysbiotech.com/news/the-importance-of-administration-volume-17529862965879808.html Betydelsen av administrationsvolym i prekliniska studier|Prisys bioteknik https://se.prisysbiotech.com/uploads/39406/news/n202508261427201a2af.gif https://se.prisysbiotech.com/news/brain-targeted-drug-delivery-17529863047767040.html Brain - riktad läkemedelsleverans|Prisys bioteknik preklinisk NHP -forskning https://se.prisysbiotech.com/uploads/39406/news/n202508221539309f4a5.jpg https://se.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17529863020094464.html ADC Drug Development|Translationellt PK/PD-ramverk i prekliniska NHP-studier https://se.prisysbiotech.com/uploads/39406/news/n2026062914295408abb.png https://se.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17501286295806976.html NHP -smärtmodeller för translationell läkemedelsupptäckt|Prisys bioteknik https://se.prisysbiotech.com/uploads/39406/news/n20250813095806db594.jpg https://se.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17501286250980352.html Serum vs. Plasma: Att välja den optimala matrisen för preklinisk bioanalys https://se.prisysbiotech.com/uploads/39406/news/n20250805095551af23f.jpg https://se.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17501286144828416.html Prekliniska doseringsriktlinjer: IV & PO volym, PH och osmolaritet för exakt PK i NHP och andra arter https://se.prisysbiotech.com/uploads/39406/news/n20250731153850aa43a.jpg https://se.prisysbiotech.com/news/nhp-copd-model-17501286102197248.html Topp COPD -forskningsmodeller & andningsplattform Excellence av Prisys https://se.prisysbiotech.com/uploads/39406/news/n20250730125053bd455.jpg https://se.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17501286073443328.html NHP Akut blödningsmodell: Ett avgörande verktyg för att påskynda nya hematologiska läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n20250722163908bd854.png https://se.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17501286104900608.html Pruritus Research: Prisys Biotechs IL-31-inducerad NHP https://se.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://se.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17456088140751872.html En guide till bedömning av-läkemedelsantikroppar (ADA). https://img01.v15cdn.com/gallery/4x3/148.webp https://se.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17456086874956800.html Andningsterapier: Prisys Biotechs integrerade NHP-plattform för preklinisk forskning https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17456086970164224.html NHP -smärtmodeller: Accelererande smärtstillande läkemedelsutveckling på Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/p20250704135241befde.png https://se.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17456086831850496.html NHP -modellplattformar för att stödja läkemedelsutveckling vid komplexa sjukdomar https://se.prisysbiotech.com/uploads/39406/news/n20250123123328c619c.jpg https://se.prisysbiotech.com/news/key-considerations-for-dosing-volume-17456086912377856.html Viktiga överväganden för doseringsvolym, PH och formulering i djurmodeller https://se.prisysbiotech.com/uploads/39406/news/n202506260936191360e.png https://se.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17456086845481984.html Konstruerade exosomer: revolutionerande läkemedelsleverans för CNS-störningar – prekliniska insikter från Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://se.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17456099714360320.html Vägledande principer för urval av djurarter i nukleinsyraläkemedelstoxikologiska studier https://img01.v15cdn.com/gallery/4x3/148.webp https://se.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17456087954547712.html Prisys Biotechs DSA och IMRI för studier av hematologiska, vaskulära och njursjukdomar https://se.prisysbiotech.com/uploads/39406/news/n20250610100231b6146.jpg https://se.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17456099575686144.html Cynomolgus Monkey Pain-modeller: driver translationell forskning för banbrytande jonkanalterapi https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17456087161037824.html Främjande atopisk dermatitforskning: Prisys Biotechs icke-mänskliga primat (NHP) -modell https://se.prisysbiotech.com/uploads/39406/news/n20250530142432192c3.jpg https://se.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17456086853493760.html Prisys Biotechs NHP Atopic Dermatitis-modell för anti-pruritisk läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/p20250527155048d3f8c.png https://se.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374209950491648.html Designa djurstudier: Viktiga överväganden för preklinisk forskningsframgång https://img01.v15cdn.com/gallery/4x3/300.webp https://se.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374209853023232.html Atopisk dermatit: Hur Cynomolgus Monkey Models Advance Precision Therapeutics https://se.prisysbiotech.com/uploads/39406/news/n2025052012503626be2.jpg https://se.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374209706091520.html Astmaforskning: varför icke-mänskliga primatmodeller är avgörande för utveckling av nya läkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374209766974464.html Förstå antisensoligonukleotid (ASO) farmakokinetik: nyckelfaktorer i absorption och distribution https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374210150622208.html NHP Inhalationsstudier för biologiska läkemedel: PRISYS specialiserade prekliniska CRO-tjänster https://img01.v15cdn.com/gallery/4x3/300.webp https://se.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374209769055232.html Avancerade prekliniska inhalationsstudier: teknisk kapacitet och expertis hos Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://se.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374209776149504.html Förstå farmakokinetik (PK): Nyckelparametrar och applikationer i läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n2025042511302920eb4.webp https://se.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374209906942976.html Intracerebroventrikulär (ICV) injektion: Precisionsleverans av CNS för preklinisk forskning https://se.prisysbiotech.com/uploads/39406/news/n2025042210212390d49.jpg https://se.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374209876321280.html Intracerebral (ICM) injektion: precisionsinriktning för CNS-terapi – prekliniska överväganden https://img01.v15cdn.com/gallery/4x3/148.webp https://se.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374209860264960.html Intratekal (IT) injektion: en direkt CNS-leveransväg för avancerade terapier – prekliniska överväganden https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374209744118784.html Avancera forskning om Parkinsons sjukdom med NHP-modellen https://img01.v15cdn.com/gallery/4x3/300.webp https://se.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374209839277056.html Prekliniska PK/PD-studier & NHP-modeller för läkemedelsutveckling|Prisys Biotech https://img01.v15cdn.com/gallery/4x3/300.webp https://se.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298416037078016.html Inriktning på Interleukin-31 (IL-31): A Novel Frontier in Autoimmune Disease Drug Development – ​​Prisys Biotech NHP-modeller för preklinisk forskning https://se.prisysbiotech.com/uploads/39406/news/n202504011023488ec4a.png https://se.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295348376462336.html Icke-klinisk immuntoxicitetsbedömning: strategi, nyckelöverväganden och metodval https://img01.v15cdn.com/gallery/4x3/232.webp https://se.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295194905322496.html Mikrobiella tester och dess inverkan på icke-mänskliga primater i prekliniska DMPK-studier https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295227483218944.html Cynomolgus Monkey Endometriosis Model for Advancing Therapeutic Research https://se.prisysbiotech.com/uploads/39406/news/n2025032013423376e5c.png https://se.prisysbiotech.com/news/membranous-nephropathy-model-17295194938647552.html Advancing Membranous Nephropathy (MN) läkemedelsutveckling: Prisys Biotechs Cynomolgus Monkey Model Platform https://img01.v15cdn.com/gallery/4x3/148.webp https://se.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295195021632512.html Farmakokinetik för inhalationsläkemedel: ett paradigmskifte från systemisk till pulmonell exponering https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/animal-models-for-womens-health-17295194738942976.html Prisys Biotech: Djurmodeller för kvinnors hälsoterapi https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295227719115776.html World Fetity Day|Prisys Biotech NHP Metabolic Models: Drivning av utvecklingen av nästa generations anti-fetma terapier https://se.prisysbiotech.com/uploads/39406/news/n2025030417050873614.png https://se.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295195036181504.html Prisys Biotechs Cynomolgus Monkey Psoriasis Model: Advancing Preclinical Pharmacodynamics Evaluation https://se.prisysbiotech.com/uploads/39406/news/n202502280925537e8ce.jpg https://se.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295195045913600.html Integration av farmakokinetik och farmakodynamik i läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/n2025022110272438f73.png https://se.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888295216522240.html On-Webinarium på begäran|The Precision Bridge: MRI-guidad CED och översättbara NHP-modeller för CNS-läkemedelsleverans https://se.prisysbiotech.com/uploads/39406/news/n202604301806570fdec.jpg https://se.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295194972169216.html Vad validerar Proof Of Concept (PoC) i läkemedelsutveckling egentligen? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295227366204416.html Djurmodeller|Utmaningar och tillämpningar i utveckling av smärtmodeller https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295194910516224.html Icke-klinisk farmakodynamisk forskning https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243129419637760.html Att välja den idealiska icke-mänskliga primaten för toxikologiska studier: Cynomolgus Makaque, Rhesus Makaque och Marmoset https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81225863.html Riktad terapi för Parkinsons sjukdom: genombrott i real-MRI-Guidad stamcellstransplantation https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295227430413312.html Systemisk lupus erythematosus (SLE) och djurmodellernas roll i terapeutisk utveckling https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295194860381184.html Icke-mänsklig primatmodell för reumatoid artrit (RA) https://se.prisysbiotech.com/uploads/39406/news/n20250117153412b3280.jpg https://se.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295227373249536.html Stereotaktiska instrument från djurhjärnan baserade på 3D-koordinatsystem https://se.prisysbiotech.com/uploads/39406/news/n20250115133928772c1.jpg https://se.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295227535746048.html Djurmodeller för in vivo-testning (1): Etablering och klassificering https://img01.v15cdn.com/gallery/4x3/148.webp https://se.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83978085.html Utforska potentiella vägar för biologiska ämnen att komma in i hjärnan https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83978019.html Att främja forskning om reumatoid artrit (RA) med icke-mänskliga primatmodeller https://se.prisysbiotech.com/uploads/39406/news/n20250102143547c190f.jpg https://se.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83978062.html Utforska djurmodeller för läkemedelseffekt vid atopisk dermatit https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83978036.html Den kritiska rollen för djurmodeller i forskning om mänskliga sjukdomar https://se.prisysbiotech.com/uploads/39406/news/n202412271723592a539.jpg https://se.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83978021.html Parkin-genbrist-apmodell avslöjar nya mekanismer och terapeutiska mål för Parkinsons sjukdom https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83978028.html Handbok för icke-klinisk läkemedelsutveckling: akuta, subakuta, subkroniska och kroniska allmänna toxicitetsstudier https://se.prisysbiotech.com/uploads/39406/news/n20241220112548bfcff.jpg https://se.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83978039.html Innovativ läkemedelsförsörjning från näsan till hjärnan (N2B): Förbigång av blod-hjärnbarriären https://se.prisysbiotech.com/uploads/39406/news/n202412161319158371d.jpg https://se.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83978018.html Möjligheter och utmaningar för minigrisar som en icke-klinisk stor djurart https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83036335.html Läkemedelsleveransstrategier för hjärnsjukdomar https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83027897.html Real-intraoperativ MRI-navigering: Stödjer FDA-godkännande av den första genterapin för AADC-brist https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83026843.html Okulära toxicitetsstudier av ögondroppar: drogexponering och säkerhetsutvärdering https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82732805.html Prisys Biotech etablerar Cynomolgus Monkey Psoriasis-modell för att påskynda läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82732819.html Omfattande icke-mänskliga primatmodeller för njursjukdomsforskning av Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82732803.html Omfattande preklinisk säkerhetsutvärdering av antikropps-läkemedelskonjugat (ADC) i icke-mänskliga primater https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82732807.html Farmakokinetisk utvärdering av antikropps-läkemedelskonjugat (ADC) i icke-humana primater https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82732802.html Farmakodynamik utvärdering av ADC https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82732804.html Förstå DMPK för ADC-läkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82732806.html Framsteg i utvecklingen av nukleinsyraläkemedel och Prisys Biotechs forskningskapacitet https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82266987.html Framsteg inom mRNA-pulmonella leveranssystem och Prisys biotechs innovativa tjänster https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82733865.html Varför tilldelades 2024 Nobelpriset i fysiologi eller medicin till dessa två forskare som studerade mikroRNA? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82732812.html Farmakokinetiska (PK) överväganden för läkemedel mot centrala nervsystemet (CNS). https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656494.html Framsteg inom CNS-forskning: Prisys Biotechs MRI-kompatibla hjärninjektionssystem och CED-teknik https://se.prisysbiotech.com/uploads/39406/news/n20260818092955a6cca.jpg https://se.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81225861.html Avancerad blödning och koagulering Terapeutiska innovationer med Cynomolgus Monkey MCAO-modell https://se.prisysbiotech.com/uploads/39406/news/n202409241700121ed48.jpg https://se.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81225857.html DMPK-utvärdering av läkemedel från centrala nervsystemet (CNS). https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/animal-models-of-human-diseases-81225853.html Djurmodeller av mänskliga sjukdomar https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81225852.html Innovations in Pain Evaluation: AI-Driven Behavioural Analysis https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/china-experimental-monkey-industry-81225855.html Historia, nuvarande status, utmaningar och möjligheter för Kinas experimentella apindustri https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/human-disease-animal-models-81226687.html Djurmodeller för mänskliga sjukdomar: ett avgörande verktyg för att främja biomedicinsk forskning https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81226194.html Vikten av preklinisk farmakodynamik i läkemedelsutveckling|Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n202608180930355ea9f.jpg https://se.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81225850.html Intranasal administrering i djurstudier https://se.prisysbiotech.com/uploads/39406/news/n2026081809304573eca.jpg https://se.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79483018.html Revolutionerande CNS-läkemedelsutveckling: PRISYS Biotech introducerar IMRI-teknik https://se.prisysbiotech.com/uploads/39406/news/n20240729151529d56e9.png https://se.prisysbiotech.com/news/convection-enhanced-delivery-81225849.html Advancing Precision Medicine: Convection-Enhanced Delivery (CED) Technology av Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20260818093109a5b18.jpg https://se.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81225854.html Cynomolgus Monkey Chronic Kidney Disease (CKD) modell av Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n20240820104326c1ab2.jpg https://se.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79548386.html Icke-klinisk säkerhetsutvärdering av okulär läkemedelsleverans med Cynomolgus Macaques https://se.prisysbiotech.com/uploads/39406/news/n2026081809313004e65.jpg https://se.prisysbiotech.com/news/compartment-pk-model-81226702.html Förstå fack- och icke--fackmodeller i farmakokinetik https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81225851.html Avancerade CNS-leveranstekniker hos Cynomolgusapor: accelererar utvecklingen av oligonukleotidläkemedel https://se.prisysbiotech.com/uploads/39406/news/n20260818093209f5a1f.jpg https://se.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79548380.html Minska användningen av icke-mänskliga primater i icke-kliniska säkerhetsbedömningar: Perspektiv från FDA och industrin https://se.prisysbiotech.com/uploads/39406/news/n20260818093218cb9d5.jpg https://se.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79548421.html LCMS preklinisk bioanalys av LNP-baserade genterapiläkemedel https://se.prisysbiotech.com/uploads/39406/news/n20260818093228e8ded.jpg https://se.prisysbiotech.com/news/mrna-based-therapies-past-79548413.html MRNA-baserade terapier: Tidigare https://se.prisysbiotech.com/uploads/39406/news/n2026081809332814450.jpg https://se.prisysbiotech.com/news/pk-strategies-of-pdc-79548376.html Farmakokinetiska studiestrategier för peptid-läkemedelskonjugat (PDC) https://se.prisysbiotech.com/uploads/39406/news/n20260818093337d1e36.jpg https://se.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79548927.html AAV:s roll i genterapi: immunsvar och toxicitet https://se.prisysbiotech.com/uploads/39406/news/n202608180933456edfc.jpg https://se.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79548390.html Optimerade icke-kliniska immunogenicitetsutvärderingsstrategier https://se.prisysbiotech.com/uploads/39406/news/n20260818093356b38f2.jpg https://se.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79548409.html Farmakodynamisk (PD) utvärdering av genterapi https://se.prisysbiotech.com/uploads/39406/news/n2026081809344882063.jpg https://se.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79548400.html Farmakokinetik och bioanalys av oligonukleotidläkemedel-(1) https://se.prisysbiotech.com/uploads/39406/news/n202608180935436ab59.jpg https://se.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79548418.html Farmakokinetik och bioanalys av oligonukleotidläkemedel: Absorptions- och plasmafarmakokinetik (PK) egenskaper https://se.prisysbiotech.com/uploads/39406/news/n2026081809363714d7b.jpg https://se.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79548404.html Faktorer att beakta för immunogeniciteten hos oligonukleotidläkemedel https://se.prisysbiotech.com/uploads/39406/news/n2026081809375929690.jpg https://se.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79548423.html MRNA: Ett kraftfullt och mångsidigt verktyg för att bekämpa sjukdomar-Prisys-Biotech https://se.prisysbiotech.com/uploads/39406/news/n2026081809383817f03.jpg https://se.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79548407.html Kinesiska forskare erbjuder nya strategier för att vända kärnsymtom på Parkinsons sjukdom https://se.prisysbiotech.com/uploads/39406/news/n20260818094028d7d16.jpg https://se.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79548396.html Prisys Biotechnology: Nya lipidnanopartiklar för MRNA-leverans i primater https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79548402.html Vikten av translationell medicinsk forskning från grundforskning till kliniska studier https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79548411.html De viktigaste faktorerna som beaktas i WOE-analys https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79548398.html Hur levererar man biologi till hjärnan? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79548393.html Hur droger rör sig och förändras i våra kroppar: en kort introduktion till farmakokinetik https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79548397.html Hur man utvecklar nya läkemedel snabbare och säkrare: En guide till prekliniska DMPK-studier https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79548412.html Riktlinjer för gruppboende för laboratorieapor https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79548391.html Experimentapors avgörande roll för att främja vetenskaplig forskning https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79548416.html Förstå Macaca Fascicularis (Cynomolgus Monkey): Nyckelegenskaper och bidrag till biomedicinsk forskning https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79548394.html Revolutionerande behandling av metabola sjukdomar: framsteg och utmaningar i utvecklingen av peptidläkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79548382.html Hur utvärderar man säkerheten hos hudprodukter före kliniska prövningar? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79548415.html Experimentapors betydelsefulla roll i innovativ läkemedelsutveckling: en inblick i verksamheten https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79548410.html Levertoxicitet som ett nyckelproblem för SiRNA-läkemedel: En omfattande analysmålspecificitet: SiRNA:s dubbeleggade-svärd https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79548383.html Advancing SiRNA Therapeutics: Att övervinna utmaningar i läkemedelsutveckling https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79548417.html Tillämpningsmöjligheter för genläkemedel baserade på lipidnanopartiklar https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79548422.html Nyckelpunkter i utformningen av strategier för icke-kliniska studier på unga djur https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79548405.html Insikt i de sensoriska och beteendemässiga egenskaperna hos icke-mänskliga primater (NHP) https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79548403.html Utvärdering av icke-klinisk studie, frågor och svar https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/significance-principles-and-requirements-of-79548424.html Betydelse, principer och krav för säkerhetsfarmakologisk forskning https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79548389.html Hur utvärderar man preklinisk farmakologisk effekt? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79548385.html Reflektioner över icke-kliniska farmakologiska studier och utvärdering av terapeutiska läkemedel för icke-alkoholisk Steatohepatit (NASH) https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79548377.html Avancering av CNS och CGT-forskning: Prisys Biotechnologies https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79548399.html Riktlinjer för insamling av icke-Human Primat Cerebrospinal Fluid https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79548426.html Överväganden för att tolka data om klinisk patologi hos icke-mänskliga primater (NHP) och hundar https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79548374.html ​​​​​​Integrera CNS-säkerhetsutvärdering i allmänna toxikologiska studier https://se.prisysbiotech.com/uploads/39406/news/n20260818092240ecd59.jpg https://se.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79548388.html Hur gör man preklinisk farmakologi/toxikologisk utvärdering av ADC? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79548384.html ADME-insikter för oligonukleotidläkemedel (1) - Absorption, distribution https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79548378.html ADME-insikter för oligonukleotidläkemedel (2) - Metabolism och utsöndring https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79548368.html Prekliniska djurstudier (1) - Djurarter https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79548372.html Utmaningar och strategier för tolkning av data för klinisk patologi i prekliniska studier av hundar och icke-mänskliga primater https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79548425.html Prekliniska djurstudier (2) - Administrationsvägar och volymer https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/mrna-based-therapies-present-79548419.html MRNA-baserade terapier: Nuvarande https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79548420.html MRNA-baserade terapier: framtid och utmaningar https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79548414.html Kort introduktion om biologisk analys av genterapi https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79483019.html Cynomolgus Monkey i Ophthalmic Drug Research https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79483020.html Translationella och tvärgående-reaktiva studier med Prisys NHP-modeller för immunologi och inflammation https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79204557.html Icke-naiva NHPs in Preclinical Trials: A Cost-Effective Solution by Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/nhp-asthma-model-79204548.html NHP Astmamodell: Bemyndigande studier av prekliniska läkemedelseffekter med Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79204544.html Avancera immunologi och inflammationsforskning med Cynomolgus Macaques-modeller - Prisys Biotechnologies https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79204547.html Direkt leverans av oligonukleotidläkemedel till CNS och vanliga histopatologiska förändringar https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79204545.html Intra-Cerebrovascular Stroke (ICH) modell av Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75175573.html Icke-klinisk farmakodynamisk forskning: en viktig aspekt i utvecklingen av SiRNA-läkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77754328.html MRT-Guidad precisionslokalisering och leveranssystem för stora djurs centrala nervsystem avgörs i Prisys Biotech https://se.prisysbiotech.com/uploads/39406/news/n2024042910594482ea8.jpg https://se.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77082269.html Innovativa lösningar för att utveckla andningsterapi https://se.prisysbiotech.com/uploads/39406/news/n202404261311431ebfc.jpg https://se.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74812941.html Prisys: Advancing Animal Experimentation Through Cynomolgus Makaque Studies https://se.prisysbiotech.com/uploads/39406/news/n2026081810523468f50.jpg https://se.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76212483.html Prisys uppnår full ackreditering från AAALAC International: En milstolpe för att säkerställa hög standard för laboratoriedjursvård. https://se.prisysbiotech.com/uploads/39406/news/n2026081810504717414.jpg https://se.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74696160.html Öka nukleinsyraterapi genom banbrytande-med Prisys Biotech Nonhuman Primate Models https://se.prisysbiotech.com/uploads/39406/news/n202608181049206508e.jpg https://se.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74215409.html Revolutionerande CNS-läkemedelsleverans: Prisys och löftet om intratekal injektion https://img01.v15cdn.com/gallery/4x3/148.webp https://se.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75175577.html Prisys Biotech 2024 Q1 Newsletter - din pålitliga NonHuman Primate-studiespecialist https://se.prisysbiotech.com/uploads/39406/news/n2024022009580247f09.jpg https://se.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73649521.html Hur ultraljud-Guidad leverbiopsi förbättrar makaker-baserad forskning https://se.prisysbiotech.com/uploads/39406/news/n20260818104547ef326.jpg https://se.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73649520.html Riktlinjer för livstidsanvändning av icke-mänskliga primater i biomedicinsk forskning: A Prisys Biotechnology Perspective https://se.prisysbiotech.com/uploads/39406/news/n202608181046546955c.jpg https://se.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73028789.html Icke-mänskliga primater: en kort introduktion till deras biologiska egenskaper https://se.prisysbiotech.com/uploads/39406/news/n20260818104755a1151.jpg https://se.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72709230.html Utställningsrecension|Prisys Biotech lyser på årsmötet i American Society for Neuroscience (SfN 2023) https://se.prisysbiotech.com/uploads/202339406/n202311211050557965049.jpg https://se.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72330240.html Möt Prisys Biotech på Society For Neurosciences årsmöte (SfN 2023) https://se.prisysbiotech.com/uploads/202339406/n202311071007243112725.jpg https://se.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72330242.html Världs strokedagen|Fokus på ischemisk stroke djurmodeller och farmakologi https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72330237.html Prisys Biotech bjuder in dig att delta i SAPA-Kinas årsmöte 2023 https://se.prisysbiotech.com/uploads/202339406/n202310271316191263008.jpg https://se.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72330239.html Världs Alzheimerdagen|Utmaningarna och lösningarna för utveckling av AD-läkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72330238.html Prisys Biotechs Cynomolgus Macaque djurmodell hjälper utvecklingen av nya antikoagulerande läkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70987122.html Prisys: Tillhandahåller hög-djurexperimenttjänst av hög kvalitet för The Novel Anti-koagulationsfaktor XI-antikropp BJTJ-1837 https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70987120.html Metod för att upprätta en Cynomolgus Monkey-modell av hypertriglyceridemi och dess tillämpning https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70987124.html Farmakologi: huvudparametrar och betydelsen av farmakokinetiken (PK) https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70987119.html Preklinisk farmakologisk utvärdering av onkolytiska virusläkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/0-70987121.html Hur små nukleinsyraläkemedel kan förändra behandlingen av CNS-sjukdomar: insikter från Prisys Biotechnology, en leverantör av NHP-sjukdomsmodeller https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70987125.html Farmakokinetik, forskningsstrategier och fallstudier av peptidläkemedel https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69665731.html Viktiga forskningspunkter för ADC Drug PK https://img01.v15cdn.com/gallery/4x3/148.webp https://se.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69667593.html Prisys Biotechnology: A Leader in NHP CNS Disease Modeling Research Platform https://se.prisysbiotech.com/uploads/202339406/n202307252159358927114.jpg https://se.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309269.html Hur man går ner i vikt och kontrollerar diabetes med GLP-1-produkter https://se.prisysbiotech.com/uploads/39406/news/n202608181233398a12e.jpg https://se.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309367.html Hur China Monkey hjälper till att genomföra preklinisk forskningseffektivitet? https://se.prisysbiotech.com/uploads/39406/news/n20260818124638529d2.jpg https://se.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309374.html Vad är effektiviteten hos RNAi? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309337.html Prisys Biotech Large Animal Experiment Public Service Platform: Låg-kostnad och hög-effektiv lösning för stora djurexperiment https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69077514.html Hur AAV-genterapi kan rädda din syn: de senaste genombrotten från icke-human primatstudier https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69076436.html Prisys Biotech visar upp icke-mänsklig primatmodellplattform vid årsmötet i Japanese Society of Toxicology https://se.prisysbiotech.com/uploads/202339406/n202306272201578501988.jpg https://se.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69080490.html Den lovande framtiden för AAV-genterapi hos icke-mänskliga primater https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69087166.html Vad är lipidnanopartiklar för genterapi? https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69075230.html Prisys Biotech bjuder in dig att delta i det 50:e årliga mötet i Japanese Society of Toxicology (JSOT) https://se.prisysbiotech.com/uploads/202339406/n202306160930293342952.jpg https://se.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69076526.html Immuntoxicitetstest, läkemedelssäkerhetsutvärdering-PRISYS BIOTECH https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68330821.html En optimal djurmodell av ischemisk stroke etablerad genom digital subtraktionsangiografi-Guidad autologa tromber hos Cynomolgus-apor https://se.prisysbiotech.com/uploads/202339406/n202306051532328723304.jpg https://se.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68126336.html Varför du bör bry dig om icke-mänskliga primater i forskning och utveckling av nukleinsyrasystem för läkemedelsleverans https://se.prisysbiotech.com/uploads/39406/news/2026081812460527f54.jpg https://se.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68126340.html Möt Prisys Biotech vid 70:e JALAS 2023! https://se.prisysbiotech.com/uploads/202339406/n202305232011515935612.jpg https://se.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68126341.html Genterapi lyser med nya godkännanden för sällsynta sjukdomar https://se.prisysbiotech.com/uploads/39406/news/n20260818112227f0067.jpg https://se.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68126337.html Revolutionerande läkemedelsupptäckt: Hur icke-mänskliga primater optimerar SiRNA-screening för snabbare och mer effektiva resultat https://se.prisysbiotech.com/uploads/39406/news/n2026081811211728443.jpg https://se.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67549541.html Maximera SiRNA-farmakologieffektiviteten med icke-mänsklig primatforskning https://se.prisysbiotech.com/uploads/39406/news/n202608181110261d729.jpg https://se.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67550182.html Hur icke-mänskliga primater kan revolutionera SiRNA-forskning: En omfattande guide https://se.prisysbiotech.com/uploads/39406/news/n202608181109402926c.jpg https://se.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67550177.html Firar världsdagen för försöksdjur: varför Prisys har åtagit sig att främja hälsan hos icke-mänskliga primater https://se.prisysbiotech.com/uploads/202339406/n202304242046033664975.jpg https://se.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67572821.html Maximera CRISPR/Cas9-forskningseffektiviteten med icke-mänskliga primatmodeller https://se.prisysbiotech.com/uploads/39406/news/n20260818110815e127c.jpg https://se.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67573808.html Frigör den terapeutiska potentialen: varför investeringar i nukleinsyraläkemedel är medicinens framtid https://se.prisysbiotech.com/uploads/39406/news/n202608181107339a708.jpg https://se.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67548904.html Låsa upp potentialen hos icke-mänskliga primater för att förbättra upptäckten av genterapi för läkemedelsmål https://se.prisysbiotech.com/uploads/39406/news/n202608181106513ac69.jpg https://se.prisysbiotech.com/news/world-parkinsons-disease-day-67560006.html Unite For Parkinsons: Joining Hands To Raise Medvetenhet på World Parkinsons Disease Day https://se.prisysbiotech.com/uploads/202339406/n202304111648126878455.jpg https://se.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67550178.html Hur man använder icke-mänskliga primater effektivt i säkerhetsutvärdering av genterapi https://se.prisysbiotech.com/uploads/39406/news/n20260818110521065c0.jpg https://se.prisysbiotech.com/news/gene-therapy-toxicology-66275612.html Genterapi Toxikologiforskning med Nonhuam Primate https://se.prisysbiotech.com/uploads/39406/news/n202608181102082f663.jpg https://se.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66137800.html En omfattande guide till att genomföra DMPK-studier för genterapi https://se.prisysbiotech.com/uploads/39406/news/n20260818110117c7822.jpg https://se.prisysbiotech.com/news/gene-therapy-nhp-model-66137796.html Revolutionerande medicinsk forskning: Genombrott inom genterapi i icke-mänskliga primatsjukdomsmodeller! https://se.prisysbiotech.com/uploads/39406/news/n20260818105650617bb.jpg https://se.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66138700.html Topp 10 populära frågor relaterade till genterapi https://se.prisysbiotech.com/uploads/39406/news/n20260818105726b2641.jpg https://se.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66138699.html Prisys Biotech: Non-Human Primate Pharmacology for Gene Therapy https://se.prisysbiotech.com/uploads/39406/news/n20260818105536d2837.jpg https://se.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66137803.html Stödja kvinnors hälsa: En titt på endometrios https://se.prisysbiotech.com/uploads/202339406/n202303080917443223214.jpg https://se.prisysbiotech.com/news/prisys-sot2023-66137799.html PRISYS och Taichu Group samarbetar för SOT-utställningen 2023 https://se.prisysbiotech.com/uploads/202339406/n202303101009207805940.jpg https://se.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66137802.html Behöver vi ytterligare studier för smärtbedömning? - NHP https://se.prisysbiotech.com/uploads/39406/news/n20260818105333c5854.jpg https://se.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66137801.html Var med och fira World Wildlife Day https://se.prisysbiotech.com/uploads/202339406/n202303031713469632535.jpg https://se.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66137797.html Prisys Shanghai NHP R&D Center lanseras och markerar en milstolpe inom läkemedelsforskning och utveckling i Kina https://se.prisysbiotech.com/uploads/202339406/n202303081340054460581.jpg https://se.prisysbiotech.com/news/meetprisys-sot2023-66137798.html Meet Prisys @ Booth No. 1434 in The Upcoming SOT Conference | US-Roadshow https://se.prisysbiotech.com/uploads/202339406/n202303031705254453292.jpg